Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Am J Hum Genet January 1, 2020; 106 (3): 338-355.

Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders.

Barbosa S , Greville-Heygate S , Bonnet M , Godwin A , Fagotto-Kaufmann C , Kajava AV , Laouteouet D , Mawby R , Wai HA , Dingemans AJM , Hehir-Kwa J , Willems M , Capri Y , Mehta SG , Cox H , Goudie D , Vansenne F , Turnpenny P , Vincent M , Cogné B , Lesca G , Hertecant J , Rodriguez D , Keren B , Burglen L , Gérard M , Putoux A , , Cantagrel V , Siquier-Pernet K , Rio M , Banka S , Sarkar A , Steeves M , Parker M , Clement E , Moutton S , Tran Mau-Them F , Piton A , de Vries BBA , Guille M , Debant A , Schmidt S , Baralle D .

The Rho-guanine nucleotide exchange factor (RhoGEF) TRIO acts as a key regulator of neuronal migration, axonal outgrowth, axon guidance, and synaptogenesis by activating the GTPase RAC1 and modulating actin cytoskeleton remodeling. Pathogenic variants in TRIO are associated with neurodevelopmental diseases, including intellectual disability (ID) and autism spectrum disorders (ASD). Here, we report the largest international cohort of 24 individuals with confirmed pathogenic missense or nonsense variants in TRIO. The nonsense mutations are spread along the TRIO sequence, and affected individuals show variable neurodevelopmental phenotypes. In contrast, missense variants cluster into two mutational hotspots in the TRIO sequence, one in the seventh spectrin repeat and one in the RAC1-activating GEFD1. Although all individuals in this cohort present with developmental delay and a neuro-behavioral phenotype, individuals with a pathogenic variant in the seventh spectrin repeat have a more severe ID associated with macrocephaly than do most individuals with GEFD1 variants, who display milder ID and microcephaly. Functional studies show that the spectrin and GEFD1 variants cause a TRIO-mediated hyper- or hypo-activation of RAC1, respectively, and we observe a striking correlation between RAC1 activation levels and the head size of the affected individuals. In addition, truncations in TRIO GEFD1 in the vertebrate model X. tropicalis induce defects that are concordant with the human phenotype. This work demonstrates distinct clinical and molecular disorders clustering in the GEFD1 and seventh spectrin repeat domains and highlights the importance of tight control of TRIO-RAC1 signaling in neuronal development.

PubMed ID: 32109419
PMC ID: PMC7058823
Article link: Am J Hum Genet
Grant support: [+]

Species referenced: Xenopus
Genes referenced: pak1 rac1 rho tubb2b
GO keywords: Rho guanyl-nucleotide exchange factor activity [+]

Disease Ontology terms: macrocephaly-autism syndrome [+]

Article Images: [+] show captions
References [+] :
Allen, PAK3 mutation in nonsyndromic X-linked mental retardation. 1998, Pubmed